ICD-10 Code C92.01 | Acute myeloblastic leukemia, in remission Symptoms, Diagnosis, Billing

Acute myeloblastic leukemia, in remission is a hematological malignancy characterized by the rapid proliferation of myeloblasts in the bone marrow. This condition is clinically significant as it requires prompt diagnosis and treatment to prevent complications. The ICD-10 Code C92.01 facilitates accurate documentation, billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.

What is ICD-10 Code C92.01 for Acute myeloblastic leukemia, in remission?

ICD-10 Code C92.01 represents Acute myeloblastic leukemia, in remission, indicating that the patient has undergone treatment and is currently free from active disease symptoms. This code is used in clinical documentation and billing to signify the patient's status, allowing for appropriate management and follow-up care.

ICD-10 Code C92.01 – Clinical Definition and Explanation of Acute myeloblastic leukemia, in remission

Acute myeloblastic leukemia, in remission, is a type of cancer that affects the blood and bone marrow, leading to the accumulation of immature white blood cells. The condition can arise from genetic mutations and environmental factors, necessitating immediate medical intervention to prevent severe complications. Regular monitoring is essential to ensure the disease remains in remission.

Key Clinical Features:

• Presence of myeloblasts in the bone marrow and peripheral blood.
• Symptoms may include fatigue, fever, and increased susceptibility to infections.
• Diagnosis typically confirmed through bone marrow biopsy and cytogenetic analysis.
• Remission is defined by the absence of disease symptoms and normalization of blood counts.

ICD-10 Code C92.01 for Acute myeloblastic leukemia, in remission – SOAP Notes & Clinical Use

ICD-10 Code C92.01 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. This code plays a crucial role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's health status and treatment response.

What Does ICD-10 Code C92.01 for Acute myeloblastic leukemia, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C92.01 connects subjective patient reports and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C92.01 – Acute myeloblastic leukemia, in remission

Management of Acute myeloblastic leukemia, in remission focuses on maintaining remission and preventing relapse. Hospitalization may be necessary for monitoring and supportive care.

Antibiotic Therapy:

• Ciprofloxacin: 500 mg orally twice daily for 7-14 days.
• Levofloxacin: 750 mg orally once daily for 7-14 days.
• Piperacillin-tazobactam: 3.375 g IV every 6 hours for 7-14 days.

Supportive Care:

• Regular blood transfusions to manage anemia.
• Growth factor support (e.g., G-CSF) to stimulate white blood cell production.
• Nutritional support to maintain overall health.

Infection Control:

• Strict hand hygiene protocols to prevent infections.
• Use of masks and isolation precautions during outbreaks.
• Regular monitoring for signs of infection.

How to Document Symptoms of Acute myeloblastic leukemia, in remission (ICD-10 C92.01) in SOAP Notes

Subjective:

• Patient reports feeling well with no current symptoms.
• Denies fever, chills, or signs of infection.
• History of fatigue but states it has improved since treatment.

Objective:

• Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
• Complete blood count shows normal white blood cell count.
• Bone marrow biopsy indicates no evidence of leukemic cells.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Acute myeloblastic leukemia, in remission (ICD-10 Code C92.01)

Assessment:

• Diagnosis: Acute myeloblastic leukemia, in remission (ICD-10 C92.01).
• Severity: Currently stable with no active disease.
• Contributing factors: Previous chemotherapy and supportive care.

Plan:

• Continue regular follow-up appointments every 3 months.
• Monitor blood counts and assess for any signs of relapse.
• Educate patient on signs of infection and when to seek care.

Treatment & Plan Section for ICD-10 Code C92.01 – Acute myeloblastic leukemia, in remission

• Continue monitoring with regular CBCs to assess blood counts.
• Provide education on lifestyle modifications to support health.
• Encourage adherence to follow-up appointments for ongoing assessment.
• Implement a plan for managing potential complications.

Using ICD-10 Code C92.01 for Acute myeloblastic leukemia, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of patient history and treatment response.
• Use C92.01 in conjunction with other relevant codes for comprehensive billing.
• Document all clinical findings clearly under Subjective (S) and Objective (O).
• Align treatment plans with clinical guidelines to support justified billing.

Related ICD-10 Codes Often Used with Acute myeloblastic leukemia, in remission

• C92.00 – Acute myeloblastic leukemia, not otherwise specified
• C92.02 – Acute myeloblastic leukemia, in relapse
• C92.10 – Acute myeloid leukemia, in remission
• C92.11 – Acute myeloid leukemia, in relapse

ICD-10 Code C92.01 in Medical Billing and Insurance for Acute myeloblastic leukemia, in remission

ICD-10 Code C92.01 is crucial for accurate billing in hospital and outpatient settings, particularly for patients in remission.

Billing Notes:

• Document all relevant clinical findings and treatment responses to support claims.
• Use C92.01 in the context of ongoing management and follow-up care.
• Ensure that all documentation aligns with payer requirements for reimbursement.

Common CPT Pairings: